Showing results (2311-2320 of 2,407) with videos related to

Sort By:
Pageof 241
Future Medicinal Chemistry|September 16, 2025
Pyrrolidine-based hybrid compounds: design, synthesis, in vitro and in vivo pharmacological properties and molecular docking studiesSenanur Taş, H Ali Döndaş, Naciye Yaktubay Döndaş, et al.
Future Medicinal Chemistry|May 15, 2025
Design and synthesis of newer 5-aryl-N-(naphthalen-2-yl)-1,3,4-oxadiazol-2-amine analogues as anticancer agentsMohamed Jawed Ahsan, Vivek Kumar, Amena Ali, et al.
Future Medicinal Chemistry|May 14, 2025
An insight into the in vivo antitumor therapeutic potential of indole-(fused) pyri(mi)dine hybridsZhi Xu, Rongqiang Li, Kexin Ding, et al.
Future Medicinal Chemistry|May 12, 2025
Unveiling the research directions for pyrrolidine-based small molecules as versatile antidiabetic and anticancer agentsShiv Kumar, Rupali Kohal, Debarshi Mondal, et al.
Future Medicinal Chemistry|May 12, 2025
Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapiesAbhay Bavishi, Hardev Vala, Shailesh Thakrar, et al.
Future Medicinal Chemistry|July 17, 2025
Green synthesis, in vitro, and in silico assessments of hydrazone-Schiff bases as potential antileishmanial agentsSadia Khan, Sher Wali Khan, Momin Khan, et al.
Future Medicinal Chemistry|July 30, 2025
The current landscape of quinazoline derivatives with in vivo anticancer therapeutic potential-part IIShanshan Huang, Zhi Xu, Yan Zhang, et al.
Future Medicinal Chemistry|August 5, 2025
Small-molecule Cathepsin K inhibitors: a medicinal chemistry perspectiveXuan Guan, Shu Cheng, Yifei Yin, et al.
Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
Future Medicinal Chemistry|November 7, 2025
Recent development of plant-derived and synthetic cannabinoids as novel antimicrobial agentsSanaa Musa, Lee Dayan
Pageof 241